Novel Investigational Approaches for the Treatment of Neovascular AMD


Dr Paul Hahn and Dr Michael Cohen explore upcoming treatments featuring innovative mechanisms of action and novel delivery systems for addressing neovascular AMD.

To watch the video series component of this episode, click here.

1:00 Retina specialists’ wish list for innovative therapies

6:40 Home OCT

8:43 Extending treatment intervals beyond four months

9:40 Therapies in the pipeline

15:00 Need for long-term retinal fluid suppression

16:00 Gene therapy

22:00 Helping patients facing end-stage vision loss

Related Videos
Ramin Tadayoni, MD, PhD | Image Credit: ASRS
© 2024 MJH Life Sciences

All rights reserved.